title: Modulation of alpha4 integrin mRNA levels is coupled to deficits in vasomotor function in rat arterioles by allylamine.
abstract: Allylamine, a selective cardiovascular toxin that induces oxidative stress, is known to alter expression of extracellular matrix and cell adhesion proteins that are central to arterial remodeling. Our goals were to determine whether AAM treatment in rats modulates integrin/matrix-dependent arteriolar function, and to what extent integrin expression correlated to these alterations. Integrins are transmembrane proteins that facilitate mechanical and molecular signaling between the extracellular matrix and cytoskeleton, and so are suitable candidates for involvement in phenotypic and functional alterations of smooth muscle in response to oxidative stress. Arg-Gly-Asp (RGD) and Leu-Asp-Val (LDV), two integrin-binding motifs found in ECM proteins such as collagens and fibronectin, are known to interact with integrins alphavbeta3 and alpha4beta1, respectively. Previously, we found that RGD containing peptides induce vasodilation through alphavbeta3, while LDV containing peptides induce vasoconstriction through alpha4beta1 of normal rat cremasteric arterioles. In allylamine-treated rats (AAM), the vasomotor response to LDV, but not RGD, was attenuated in a dose-dependent manner. To determine whether changes in integrin subunit mRNA levels correlated with these functional changes, we performed reverse transcription and Real-time PCR for alpha4 and beta3 integrin subunits on RNA isolated from single, first-order cremasteric arterioles. AAM treatment caused a dose-dependent decrease in alpha4 mRNA expression, but not beta3 mRNA expression, suggesting that the changes in vasomotor activity to LDV peptides may be attributable in part to reduced alpha4 expression upon exposure to AAM. These data are supported by similar decreases in alpha4integrin cell surface protein expression in cultured vascular smooth muscle cells treated either in vivo and in vitro with AAM.
authors.affiliation: Department of Medical Physiology and Cardiovascular Research Institute, The Texas A and M University System Health Science Center, 366 Reynolds Bldg., College Station, TX 77843-1114, USA.
authors.forename: Jessemy D
authors.initials: JD
authors.lastname: Neiger
authors.forename: Tracy Y
authors.initials: TY
authors.lastname: Crow
authors.forename: Charles R
authors.initials: CR
authors.lastname: Partridge
authors.forename: E Spencer
authors.initials: ES
authors.lastname: Williams
authors.forename: Jun-Tzu
authors.initials: JT
authors.lastname: Chao
authors.forename: Kenneth S
authors.initials: KS
authors.lastname: Ramos
authors.forename: Gerald A
authors.initials: GA
authors.lastname: Meininger
authors.forename: Emily
authors.initials: E
authors.lastname: Wilson
mesh_terms: D000499:Allylamine / Q000633:toxicity*; D000818:Animals; D001160:Arterioles / Q000187:drug effects / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D039441:Integrin alpha4 / Q000096:biosynthesis*; D039661:Integrin beta3 / Q000096:biosynthesis; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000378:metabolism; D012333:RNA, Messenger / Q000096:biosynthesis*; D051381:Rats; D017207:Rats, Sprague-Dawley; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014661:Vasoconstriction / Q000187:drug effects*
chemical_list: D039661:Integrin beta3; D012333:RNA, Messenger; D039441:Integrin alpha4; D000499:Allylamine